Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03845036 · ClinicalTrials.gov registry record · NA

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

A NA study of Peripheral Artery Disease and Claudication, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT03845036 is a NA study of Peripheral Artery Disease and Claudication that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 150 participants, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03845036, a NA study of Peripheral Artery Disease and Claudication, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

Interventions

  • BEHAVIORAL DASH Diet plus Home-Based Exercise
  • BEHAVIORAL Home-Based Exercise

Study Locations (1)

Oklahoma

  • O'Donoghue Research Building, University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-09-16
Est. Completion 2029-05-31
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT03845036

The ClinicalTrials.gov registry entry for NCT03845036 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (21% higher). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which DASH Diet plus Home-Based Exercise is the first listed.

NCT03845036 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03845036 about?

NCT03845036 is a clinical study titled "The Effects of Diet and Exercise Interventions in Peripheral Artery Disease". This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

What is the current status of trial NCT03845036?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-09-16. Estimated completion is 2029-05-31.

What conditions does trial NCT03845036 study?

This clinical trial studies the following conditions: Peripheral Artery Disease, Claudication.

What interventions are being tested in trial NCT03845036?

The interventions under investigation include: DASH Diet plus Home-Based Exercise (BEHAVIORAL), Home-Based Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03845036?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03845036 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.